FDA records identify Strongback Mobility AG C/O Blueaudit GmbH as the applicant on a single premarket notification in the linked collection, K253762, received November 25, 2025 and decided September 22, 2026 as substantially equivalent. The device is ErgoSteel (ES0001/696), classified as a mechanical wheelchair in Class I, reserved, with Physical Medicine as the advisory committee. The manufacturer’s own materials describe the STRONGBACK line as ergonomic wheelchairs and rollators designed around the spine’s natural S-curve, and the ErgoSteel user manual presents the product as a compact, foldable wheelchair with the STRONGBACK system. [1][2][4][8]
The documented FDA filing
K253762 lists Strongback Mobility AG C/O Blueaudit GmbH as applicant, with Roman Hefle as contact, and names ErgoSteel (ES0001/696) as the trade/device name. The record shows a Traditional clearance type, no third-party review, a Summary statement, and a decision of Substantially Equivalent (SESE) dated September 22, 2026. The regulation is 21 CFR 890.3850, Mechanical Wheelchair, Class I, reserved, product code IOR, under the Physical Medicine advisory committee. [1][2][4]
The linked collection contains one record, and its decision count is one SESE; the explicitly smaller record sample likewise holds one SESE entry, which is the same K253762 filing. These counts describe the linked filings as retrieved, not company sales, total portfolio or safety performance. [1][4]
Product identity and published description
The manufacturer’s website describes Strongback Mobility as an ergonomic wheelchair and rollator brand headquartered in Switzerland, operating through subsidiaries in the USA and Europe, and states that its products are designed to support the body’s natural alignment. The site lists product lines including the Excursion transport wheelchair and the Comfort self-propelled wheelchair, and the US site presents the Strongback ErgoSteel wheelchair among featured products. [3][5][6]
The ErgoSteel instructions for use, version 1.0 with revision 01_2026 and item number UM109, describe the STRONGBACK ERGOSTEEL as a compact, foldable wheelchair designed for a comfortable and ergonomic sitting position. The manual carries contact addresses in Düsseldorf, Germany and Virginia Beach, Virginia, and the US site lists Strongback Mobility USA, LLC in Virginia Beach. [7][8]
Applicant, brand and addresses
The FDA applicant string is Strongback Mobility AG C/O Blueaudit GmbH, and the filing address is Schindellegistrasse 73, Pfaeffikon, Switzerland. The manufacturer’s site gives its headquarters as Strongback Mobility AG, Schindellegistrasse 73, 8808 Pfäffikon SZ, Switzerland. The FDA letter is addressed to Roman Hefle, Quality Manager, at a Wolfhagen, Germany address, which is a correspondence address in the record rather than a verified headquarters. [1][2][3][5]
The relationship between the named FDA applicant and the Strongback brand is documented through the shared device name and the manufacturer’s published product pages; no parent, owner or affiliate structure beyond the stated subsidiaries is established in these sources. [1][3][5]
Scope and limits of the record
The filing covers ErgoSteel (ES0001/696) as a mechanical wheelchair; the sources do not describe clearance of the Excursion, Comfort or rollator lines, and no recall records appear in the linked collection. Warranty terms are stated by the manufacturer to vary by model and to be listed on individual product pages. [1][3][5][6]
Commercial availability, pricing, customers and clinical performance are not established by the FDA records or the manufacturer’s pages reviewed here. The US site notes free shipping on Strongback wheelchairs in the contiguous US and a dealer program, which are commercial statements published by the manufacturer rather than regulatory findings. [6][7]
